NCT04353531

Brief Summary

Massive number of clinicians were infected during the outbreak of COVID-19, which raised the concerns of utilizing "aerosol generating procedures", particularly the use of high-flow nasal cannula, noninvasive ventilation, intubation, bronchoscopy examination and pulmonary function test. There appears to be a trend to avoid those treatments. Instead, aggressive intubation might cause shortage of medical devices and add extra workload. Therefore, we aimed to do a clinical observational study to evaluate the aerosol generation in these procedures and explore the potential measures to reduce the aerosol generation or dispersion.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started May 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 23, 2020

Completed
28 days until next milestone

First Posted

Study publicly available on registry

April 20, 2020

Completed
1 month until next milestone

Study Start

First participant enrolled

May 20, 2020

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2020

Completed
Last Updated

April 23, 2021

Status Verified

April 1, 2021

Enrollment Period

3 months

First QC Date

March 23, 2020

Last Update Submit

April 21, 2021

Conditions

Outcome Measures

Primary Outcomes (8)

  • The aerosol mass/count concentration pre procedure/treatment at 1 foot away from patient

    The aerosol mass/count concentration pre procedure/treatment at 1 foot away from patient's airway in the patient's room

    5 minutes before procedure/treatment

  • The virus load in the air sample pre procedure/treatment at 1 foot away from patient

    The virus load in the air sample pre procedure/treatment at 1 foot away from patient's airway in the patient's room

    1 hour before procedure/treatment

  • The virus load in the air sample during/after procedure/treatment at 1 foot away from patient

    The virus load in the air sample during/after procedure/treatment at 1 foot away from patient's airway in the patient's room

    1 hour during/after procedure/treatment

  • The aerosol mass/count concentration pre procedure/treatment at 3 feet away from patient

    The aerosol mass/count concentration pre procedure/treatment at 3 feet away from patient's airway in the patient's room

    5 minutes before procedure/treatment

  • The aerosol mass/count concentration and virus load in the air sample during procedure/treatment at 1 foot away from patient

    The aerosol mass/count concentration and virus load in the air sample during procedure/treatment at 1 foot away from patient's airway in the patient's room

    during procedure/treatment

  • The aerosol mass/count concentration during procedure/ treatment at 3 feet away from patient

    The aerosol mass/count concentration during procedure/ treatment at 3 feet away from HFNC in the patient's room

    during procedure/treatment

  • The aerosol mass/count concentration post procedure/ treatment at 1 foot away from patient

    The aerosol mass/count concentration post procedure/ treatment at 1 foot away from HFNC in the patient's room

    5 minutes post procedure/treatment

  • The aerosol mass/count concentration 5 mins post procedure/ treatment at 3 feet away from patient

    The aerosol mass/count concentration 5 mins procedure/ treatment at 3 feet away from HFNC in the patient's room

    5 minutes post procedure/treatment

Interventions

High-flow nasal cannula is a modality of oxygen device that can provide gas flow meets or exceeds patient inspiratory flow demand (flow can be set at 10-60 L/min), it has been proven to improve oxygenation and reduce intubation rate in hypoxemic patients.

Also known as: HFNC, high-flow high humidity nasal cannula

A procedure mask will be used to cover patient's face after HFNC is initiated.

Also known as: procedure mask

is a procedure that allows a doctor to examine the inside of the lungs, including the bronchi, which are the main pathways into the lungs. During a bronchoscopy, a doctor inserts a thin tube containing a light and camera into the lungs through the nose or mouth or via artificial airway such as intubation or tracheotomy tube

intubationPROCEDURE

Intubation is the process of inserting a tube, called an endotracheal tube (ET), through the mouth and then into the airway. This is done so that a patient can be placed on a ventilator to assist with breathing during anesthesia, sedation, or severe illness.

tracheostomyPROCEDURE

A tracheostomy is a medical procedure - either temporary or permanent - that involves creating an opening in the neck in order to place a tube into a person's windpipe. The tube is inserted through a cut in the neck below the vocal cords. This allows air to enter the lungs.

A nebulizer is a piece of medical equipment that a person with asthma or another respiratory condition can use to administer medication directly and quickly to the lungs

Pulmonary function tests (PFTs) are noninvasive tests that show how well the lungs are working. The tests measure lung volume, capacity, rates of flow, and gas exchange.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients who are diagnosed as COVID-19 infection and admitted to adult ICU will be enrolled in Rush University Medical Center, Chicago, IL, USA. Patients will be excluded if patients do not require any respiratory treatments.

You may qualify if:

  • Adult patients who are diagnosed as COVID-19 infection in ICU or Adult patients are indicated for pulmonary function tests

You may not qualify if:

  • No need for any respiratory therapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rush university medical center

Chicago, Illinois, 60612, United States

Location

Related Publications (6)

  • Ong SWX, Tan YK, Chia PY, Lee TH, Ng OT, Wong MSY, Marimuthu K. Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient. JAMA. 2020 Apr 28;323(16):1610-1612. doi: 10.1001/jama.2020.3227.

    PMID: 32129805BACKGROUND
  • Hui DS, Chow BK, Lo T, Tsang OTY, Ko FW, Ng SS, Gin T, Chan MTV. Exhaled air dispersion during high-flow nasal cannula therapy versus CPAP via different masks. Eur Respir J. 2019 Apr 11;53(4):1802339. doi: 10.1183/13993003.02339-2018. Print 2019 Apr.

    PMID: 30705129BACKGROUND
  • Leung CCH, Joynt GM, Gomersall CD, Wong WT, Lee A, Ling L, Chan PKS, Lui PCW, Tsoi PCY, Ling CM, Hui M. Comparison of high-flow nasal cannula versus oxygen face mask for environmental bacterial contamination in critically ill pneumonia patients: a randomized controlled crossover trial. J Hosp Infect. 2019 Jan;101(1):84-87. doi: 10.1016/j.jhin.2018.10.007. Epub 2018 Oct 15.

    PMID: 30336170BACKGROUND
  • Hui DS, Chow BK, Chu L, Ng SS, Lee N, Gin T, Chan MT. Exhaled air dispersion during coughing with and without wearing a surgical or N95 mask. PLoS One. 2012;7(12):e50845. doi: 10.1371/journal.pone.0050845. Epub 2012 Dec 5.

    PMID: 23239991BACKGROUND
  • Johnson DF, Druce JD, Birch C, Grayson ML. A quantitative assessment of the efficacy of surgical and N95 masks to filter influenza virus in patients with acute influenza infection. Clin Infect Dis. 2009 Jul 15;49(2):275-7. doi: 10.1086/600041.

    PMID: 19522650BACKGROUND
  • Li J, Jing G, Fink JB, Porszasz J, Moran EM, Kiourkas RD, McLaughlin R, Vines DL, Dhand R. Airborne Particulate Concentrations During and After Pulmonary Function Testing. Chest. 2021 Apr;159(4):1570-1574. doi: 10.1016/j.chest.2020.10.064. Epub 2020 Nov 1. No abstract available.

MeSH Terms

Interventions

IntubationTracheostomyRespiratory Function Tests

Intervention Hierarchy (Ancestors)

TherapeuticsInvestigative TechniquesAirway ManagementOstomySurgical Procedures, OperativeOtorhinolaryngologic Surgical ProceduresThoracic Surgical ProceduresDiagnostic Techniques, Respiratory SystemDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Jie Li, PhD

    Rush University Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 23, 2020

First Posted

April 20, 2020

Study Start

May 20, 2020

Primary Completion

August 30, 2020

Study Completion

August 30, 2020

Last Updated

April 23, 2021

Record last verified: 2021-04

Locations